Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Pediatr Res ; 75(5): 603-11, 2014 May.
Article in English | MEDLINE | ID: mdl-24463490

ABSTRACT

BACKGROUND: Gender is increasingly recognized as an important influence on brain development, disease susceptibility, and response to pharmacologic/rehabilitative treatments. In regenerative medicine, it remains entirely unknown whether there is an interaction between transplanted stem cells and host gender that might bias efficacy and safety in some patients but not others. METHODS: We examined the role of recipient gender in a neonatal rat hypoxic-ischemic injury (HII) model, treated with female human neuronal stem cells (hNSCs), labeled with superparamagnetic iron oxide particles implanted into the contralateral cerebral ventricle. We monitored HII evolution (by magnetic resonance imaging, histopathology, behavioral testing) and hNSC fate (migration, replication, viability). RESULTS: Recipient gender after implantation did not influence the volume or location of ischemic injury (1, 30, or 90 d) or behavior (90 d). Superparamagnetic iron oxide labeling did not influence HII evolution. Implantation had its greatest benefit on mild/moderate injuries, which remained stable rather than increasing as in severe HII as is the natural history for such lesions. CONCLUSION: Our results suggest that hNSC treatment (including using hNSCs that are prelabeled with iron to allow tracking in real time by magnetic resonance imaging) would be equally safe and effective for male and female human newborns with mild-to-moderate HII.


Subject(s)
Hypoxia-Ischemia, Brain/pathology , Hypoxia-Ischemia, Brain/therapy , Neural Stem Cells/cytology , Sex Factors , Stem Cell Transplantation , Animals , Behavior, Animal , Female , Ferric Compounds/chemistry , Magnetic Resonance Imaging , Male , Neural Stem Cells/transplantation , Rats
2.
J Cereb Blood Flow Metab ; 32(12): 2161-70, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22929436

ABSTRACT

Neonatal hypoxic-ischemic brain injury (HII) and arterial ischemic stroke (AIS) result in irreversibly injured (core) and salvageable (penumbral) tissue regions. Identification and reliable quantification of salvageable tissue is pivotal to any effective and safe intervention. Magnetic resonance imaging (MRI) is the current standard to distinguish core from penumbra using diffusion-perfusion mismatch (DPM). However, subtle MR signal variations between core-penumbral regions make their visual delineation difficult. We hypothesized that computational analysis of MRI data provides a more accurate assessment of core and penumbral tissue evolution in HII/AIS. We used two neonatal rat-pup models of HII/AIS (unilateral and global hypoxic-ischemia) and clinical data sets from neonates with AIS to test our noninvasive, automated computational approach, Hierarchical Region Splitting (HRS), to detect and quantify ischemic core-penumbra using only a single MRI modality (T2- or diffusion-weighted imaging, T2WI/DWI). We also validated our approach by comparing core-penumbral images (from HRS) to DPM with immunohistochemical validation of HII tissues. Our translational and clinical data results showed that HRS could accurately and reliably distinguish the ischemic core from penumbra and their spatiotemporal evolution, which may aid in the vetting and execution of effective therapeutic interventions as well as patient selection.


Subject(s)
Brain Injuries/pathology , Brain Ischemia/pathology , Brain/pathology , Infant, Newborn, Diseases/pathology , Magnetic Resonance Angiography , Animals , Animals, Newborn , Brain/metabolism , Brain Injuries/metabolism , Brain Ischemia/metabolism , Female , Humans , Immunohistochemistry , Infant, Newborn , Infant, Newborn, Diseases/metabolism , Male , Rats
3.
Brain Res ; 1262: 16-24, 2009 Mar 25.
Article in English | MEDLINE | ID: mdl-19401161

ABSTRACT

In the lateral hypothalamus (LH), the inhibitory amino acid neurotransmitter, GABA, has had a long-standing presumptive role as an inhibitor of food intake. However, minimal investigation has been focused on GABA, especially as compared to the attention received by many peptide transmitters. To begin to address this deficiency in the understanding of the role of GABA in the LH and feeding, we report that antagonism of GABA(A) receptors in the rat LH elicits feeding, consistent with previous findings, and provide evidence for the behavioral selectivity of this effect. We extend previous findings that activation of LH GABA(A) receptors suppresses feeding, in particular by showing that nighttime and deprivation-induced eating are dramatically suppressed. Finally, we show that chronic activation, but not blockade, of the LH GABA(A) receptors leads to a reduction in 24 h food intake with concomitant body weight loss. These data collectively suggest that activation of GABA(A) receptors plays a fundamental role in controlling food intake and body weight, a role that has previously been somewhat underestimated.


Subject(s)
Body Weight/physiology , Hypothalamic Area, Lateral/physiology , Receptors, GABA-A/physiology , Satiety Response/physiology , Animals , Body Weight/drug effects , Dose-Response Relationship, Drug , Feeding Behavior/drug effects , Feeding Behavior/physiology , GABA Agonists/pharmacology , GABA Antagonists/pharmacology , Male , Motor Activity/drug effects , Motor Activity/physiology , Muscimol/pharmacology , Picrotoxin/pharmacology , Rats , Rats, Sprague-Dawley , Satiety Response/drug effects
4.
Brain Res ; 1283: 65-72, 2009 Aug 04.
Article in English | MEDLINE | ID: mdl-19501070

ABSTRACT

The lateral hypothalamus (LH) is a site of integration for control mechanisms of feeding behavior as it has extensive reciprocal connections with multiple intrahypothalamic and extrahypothalamic brain areas. Evidence suggests that blockade of ionotropric gamma-aminobutyric acid (GABA) receptors in the LH elicits eating in satiated rats. To determine whether this GABA(A) receptor antagonist effect is specific to the LH, the antagonist picrotoxin was injected into one of six nearby sites and food intake was measured. Picrotoxin at 133 pmol elicited eating in the LH, but not in surrounding sites (thalamus, lateral preoptic area, ventral tegmental area, dorsomedial hypothalamus, and entopeduncular nucleus). More specifically, picrotoxin injected into the tuberal LH (tLH) elicited eating, but was ineffective when injected into the anterior or posterior LH. We also investigated whether GABA(B) receptors in the LH participated in the control of food intake and found that neither blockade nor activation of these receptors under multiple conditions changed food intake. Collectively, our findings suggest that GABA(A) but not GABA(B) receptors in the tLH act to suppress feeding behavior.


Subject(s)
Appetite Regulation/physiology , Hypothalamic Area, Lateral/metabolism , Neural Inhibition/physiology , Receptors, GABA-A/metabolism , gamma-Aminobutyric Acid/metabolism , Animals , Appetite Regulation/drug effects , Feeding Behavior/drug effects , Feeding Behavior/physiology , GABA Antagonists/pharmacology , Hypothalamic Area, Lateral/drug effects , Male , Neural Inhibition/drug effects , Picrotoxin/pharmacology , Rats , Rats, Sprague-Dawley , Receptors, GABA-A/drug effects , Receptors, GABA-B/drug effects , Receptors, GABA-B/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL